Havrdova E, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Relapsing Multiple Sclerosis in the OPERA I and OPERA II Trials. EAN 2017, PR1092.
Heterogeniteit in de ziekte van Alzheimer – een data-gedreven benadering
apr 2020 | Dementie